Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
5don MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
A pair of patients with Waldenstrom’s non-Hodgkins lymphoma (NHL) remain in complete remission (CR) after 7 and 15 months ...
It's Blossom on MSN
Food & Drug Experts Say New Kidney Cell Therapy Could Transform Chronic Disease Treatment
ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...
News-Medical.Net on MSN
Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Some parts of our bodies bounce back from injury in fairly short order. The outer protective layer of the eye—called the ...
3don MSN
Sugar Land OKs $1M incentive to stem cell therapy firm as city develops life sciences ecosystem
Sugar Land has authorized an $1 million incentive for stem cell therapy company Hope Biosciences as city leaders look to ...
A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant.
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results